Azithromycin to prevent lung infections in kids with damaged lungs
Treatments studied
Part of Bones, joints & muscles, Genetic & congenital, Heart & circulation, Lungs & breathing, Skin clinical trials.
This trial tests whether a low-dose antibiotic (azithromycin) can prevent lung infections in young children with structural lung damage. It aims to see if taking it regularly can keep their lungs healthier and reduce the need for antibiotics.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your child must be between birth and 6 years old.
- They must have a confirmed structural lung problem or airway malformation, seen on CT scan or bronchoscopy.
- Your child must be followed at one of the specialized pediatric lung centers in Denmark.
- They should be at risk for or already have had lung infections needing antibiotics.
- Your child cannot have cystic fibrosis, primary ciliary dyskinesia, certain heart or liver/kidney conditions, or an allergy to azithromycin.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a common antibiotic called azithromycin can help prevent flare-ups (sudden worsening) of bronchiectasis—a lung condition where airways become permanently enlarged and damaged. Patients will take azithromycin or a placebo for 12 months to see if it reduces how often they get sick.
This trial tests whether the antibiotic azithromycin can help children in the hospital who are having asthma-like breathing symptoms. If you qualify, your child may get azithromycin as part of the study and will be monitored closely for side effects and breathing improvement.
This trial tests whether adding the antibiotic azithromycin to standard asthma treatments helps children with severe asthma in the pediatric intensive care unit (PICU) recover faster. It is for children ages 3 to 17 who are already receiving strong asthma medicines and steroids.
This trial tests whether azithromycin (an antibiotic) can improve outcomes for babies and young children in the ICU who have RSV causing serious breathing problems. It mainly looks at children who start strong breathing support soon after RSV symptoms begin.
This Phase 4 study tests whether a long course of azithromycin can reduce flare-ups in people with chronic obstructive pulmonary disease (COPD) who have had recent exacerbations. It also looks at mucus properties and how flare-ups happen.
This trial tests whether giving azithromycin to newborns who are smaller at birth can improve health outcomes in the first weeks of life. Your baby may be eligible if they meet specific age, feeding, and safety requirements.
Hear when a new Tracheomalacia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.